Skip to main content
Log in

The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Clinicians and patients differ concerning the goals of treatment. Eighty individuals with schizophrenia were assessed online about which symptoms they consider the most important for treatment, as well as their experience with different interventions. Treatment of affective and neuropsychological problems was judged as more important than treatment of positive symptoms (p < 0.005). While most individuals had experience with Occupational and Sports Therapy, only a minority had received Cognitive-Behavioral Therapy, Family Therapy, and Psychoeducation with family members before. Patients appraised Talk, Psychoanalytic, and Art Therapy as well as Metacognitive Training as the most helpful treatments. Clinicians should carefully take into consideration patients’ preferences, as neglect of consumers’ views may compromise outcome and adherence to treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Way BB, Banks S (2001) Clinical factors related to admission and release decisions in psychiatric emergency services. Psychiatr Serv 52:214–218

    Article  CAS  PubMed  Google Scholar 

  2. Addington DE, Beck C, Wang J et al (2010) Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatr Serv 61:483–488. doi:10.1176/appi.ps.61.5.483

    Article  PubMed  Google Scholar 

  3. Kuhnigk O, Slawik L, Meyer J et al (2012) Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers. J Psychiatr Pract 18:321–328. doi:10.1097/01.pra.0000419816.75752.65

    Article  PubMed  Google Scholar 

  4. Peralta V, Cuesta MJ (2009) Characterization of affective domains within the nonaffective psychotic disorders. Schizophr Res 111:61–69. doi:10.1016/j.schres.2009.03.008

    Article  PubMed  Google Scholar 

  5. Cotton SM, Lambert M, Schimmelmann BG et al (2012) Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophr Res 134:20–26. doi:10.1016/j.schres.2011.08.018

    Article  CAS  PubMed  Google Scholar 

  6. Moritz S, Cludius B, Hottenrott B et al (2015) Mindfulness and relaxation treatment reduce depressive symptoms in individuals with psychosis. Eur Psychiatry. doi:10.1016/j.eurpsy.2015.05.002

    PubMed  Google Scholar 

  7. Van der Valk R, Van de Waerdt S, Meijer CJ et al (2013) Feasibility of mindfulness-based therapy in patients recovering from a first psychotic episode: a pilot study. Early Interv Psychiatry 7:64–70. doi:10.1111/j.1751-7893.2012.00356.x

    Article  PubMed  Google Scholar 

  8. Chadwick P (2014) Mindfulness for psychosis. Br J Psychiatry 204:333–334. doi:10.1192/bjp.bp.113.136044

    Article  PubMed  Google Scholar 

  9. Khoury B, Lecomte T, Fortin G et al (2013) Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev 33:763–771. doi:10.1016/j.cpr.2013.05.005

    Article  PubMed  Google Scholar 

  10. Hasson-Ohayon I, Kravetz S, Levy I, Roe D (2009) Metacognitive and interpersonal interventions for persons with severe mental illness: theory and practice. Isr J Psychiatry Relat Sci 46:141–148

    PubMed  Google Scholar 

  11. White R, Gumley A, McTaggart J et al (2011) A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis. Behav Res Ther 49:901–907. doi:10.1016/j.brat.2011.09.003

    Article  PubMed  Google Scholar 

  12. Johnson DP, Penn DL, Fredrickson BL et al (2009) Loving-kindness meditation to enhance recovery from negative symptoms of schizophrenia. J Clin Psychol 65:499–509. doi:10.1002/jclp.20591

    Article  PubMed  Google Scholar 

  13. Moritz S, Rietschel L, Veckenstedt R, Bohn F, Schneider BC, Lincoln TM, Karow A (2015) The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis. Psychosis 7:14–24. doi:10.1080/17522439.2013.865137

    Article  Google Scholar 

  14. Moritz S, Favrod J, Andreou C et al (2013) Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull 39:917–922. doi:10.1093/schbul/sbs005

    Article  PubMed  Google Scholar 

  15. Lasalvia A, Boggian I, Bonetto C et al (2012) Multiple perspectives on mental health outcome: needs for care and service satisfaction assessed by staff, patients and family members. Soc Psychiatry Psychiatr Epidemiol 47:1035–1045. doi:10.1007/s00127-011-0418-0

    Article  PubMed  Google Scholar 

  16. Hamann J, Mendel R, Cohen R et al (2009) Psychiatrists’ use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 60:1107–1112. doi:10.1176/appi.ps.60.8.1107

    Article  PubMed  Google Scholar 

  17. Rosenheck R, Stroup S, Keefe RSE et al (2005) Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 187:529–534. doi:10.1192/bjp.187.6.529

    Article  PubMed  Google Scholar 

  18. Byrne R, Davies L, Morrison AP (2010) Priorities and preferences for the outcomes of treatment of psychosis: a service user perspective. Psychosis 2:210–217. doi:10.1080/17522430903456913

    Article  Google Scholar 

  19. Berry K, Haddock G (2008) The implementation of the NICE guidelines for schizophrenia: barriers to the implementation of psychological interventions and recommendations for the future. Psychol Psychother 81:419–436. doi:10.1348/147608308X329540

    Article  PubMed  Google Scholar 

  20. Bechdolf A, Klingberg S (2014) Psychotherapie bei schizophrenen Störungen: kein Evidenz-, sondern ein Implementierungsproblem [Psychotherapy of schizophrenia: Not a problem of evidence, but a problem of implementation]. Psychiatr Prax 41:8–10. doi:10.1055/s-0033-1359957

    Article  PubMed  Google Scholar 

  21. Puschner B, Vauth R, Jacobi F, Becker T (2006) Bedeutung von Psychotherapie in der Versorgung von Menschen mit schizophrenen Störungen in Deutschland: wie evidenzbasiert ist die Praxis? [Importance of psychotherapy in the health care of individuals with schizophrenia in Germany]. Nervenarzt 77:1301–1309. doi:10.1007/s00115-006-2102-2

    Article  CAS  PubMed  Google Scholar 

  22. Haddock G, Eisner E, Boone C et al (2014) An investigation of the implementation of NICE-recommended CBT interventions for people with schizophrenia. J Ment Health 23:162–165. doi:10.3109/09638237.2013.869571

    Article  PubMed  Google Scholar 

  23. Rummel-Kluge C, Pitschel-Walz G, Bäuml J, Kissling W (2006) Psychoeducation in schizophrenia–results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 32:765–775. doi:10.1093/schbul/sbl006

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bundespsychotherapeutenkammer [Chamber of German Psychotherapists] (2014) BPtK-Studie zur stationären Versorgung psychisch kranker Menschen. Ergebnisse einer Befragung der in Krankenhäusern angestellten Psychotherapeuten [Study of the German chamber of psychotherapists about inpatient care in people with psychological disorders]. Bundespsychotherapeutenkammer, Berlin (Germany)

  25. Prytys M, Garety PA, Jolley S et al (2011) Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: a qualitative analysis of the attitudes of CMHT staff. Clin Psychol Psychother 18:48–59. doi:10.1002/cpp.691

    Article  CAS  PubMed  Google Scholar 

  26. Jaeger S, Wachter C, Steiner T (2014) Nicht-medikamentöse therapeutische Maßnahmen bei Schizophrenie—Was kennen Patienten? Was finden sie hilfreich? [Non-pharmacological therapeutic measures in schizophrenia—what do patients know? What do they judge as helpful?] DGPPN Kongress 2014

  27. Stefanis NC, Hanssen M, Smirnis NK et al (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358. doi:10.1017/S0033291701005141

    Article  CAS  PubMed  Google Scholar 

  28. Moritz S, Van Quaquebeke N, Lincoln TM et al (2013) Can we trust the internet to measure psychotic symptoms? Schizophr Res Treat 2013:457010. doi:10.1155/2013/457010

    Google Scholar 

  29. Montag C, Haase L, Seidel D et al (2014) A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS ONE 9:e112348. doi:10.1371/journal.pone.0112348

    Article  PubMed  PubMed Central  Google Scholar 

  30. Deutsche Gesellschaft für Psychiatrie P und N (DGPPN) (eds) (2006) S3 Praxisleitlinien. Band 1 Behandlungsleitlinie Schizophrenie [S3 guidelines. Volume 1. Treatment guideline for schizophrenia]. Steinkopff, Darmstadt

  31. Gosling SD, Vazire S, Srivastava S, John OP (2004) Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. Am Psychol 59:93–104. doi:10.1037/0003-066X.59.2.93

    Article  PubMed  Google Scholar 

  32. Schneider F, Falkai P, Maier W (2012) Psychiatrie 2020. Perspektiven, Chancen und Herausforderungen [Psychiatry 2020. Perspectives, chance and challenges]. Springer, Heidelberg

    Google Scholar 

  33. Sun SX, Liu GG, Christensen DB, Fu AZ (2007) Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 23:2305–2312. doi:10.1185/030079907X226050

    Article  PubMed  Google Scholar 

  34. Emsley R, Chiliza B, Asmal L, Harvey BH (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13:50. doi:10.1186/1471-244X-13-50

    Article  PubMed  PubMed Central  Google Scholar 

  35. Eiring Ø, Landmark BF, Aas E et al (2015) What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders. BMJ Open 5:e007848. doi:10.1136/bmjopen-2015-007848

    Article  PubMed  PubMed Central  Google Scholar 

  36. Naber D, Lambert M (2013) Should we listen and talk more to our patients? World Psychiatry 12:237–238. doi:10.1002/wps.20066

    Article  PubMed  PubMed Central  Google Scholar 

  37. Suzuki T, Uchida H, Takeuchi H et al (2014) A review on schizophrenia and relapse–a quest for user-friendly psychopharmacotherapy. Hum Psychopharmacol 29:414–426. doi:10.1002/hup.2421

    Article  PubMed  Google Scholar 

  38. Westermann S, Cavelti M, Heibach E, Caspar F (2015) Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia. Front Psychol 6:1294. doi:10.3389/fpsyg.2015.01294

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steffen Moritz.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moritz, S., Berna, F., Jaeger, S. et al. The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. Eur Arch Psychiatry Clin Neurosci 267, 335–339 (2017). https://doi.org/10.1007/s00406-016-0694-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-016-0694-5

Keywords

Navigation